Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-2334
Fax+1 617-632-3479
Dr. Wright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2006 - 2009- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
Perelman School of Medicine at the University of PennsylvaniaClass of 2003
Certifications & Licensure
MA State Medical License 2005 - 2026
CT State Medical License 2022 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of an Intervention to Improve Problem List Accuracy and Use Start of enrollment: 2010 May 01
- The HOPE Trial and the SMART Study Start of enrollment: 2017 Apr 12
- Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer Start of enrollment: 2018 Jul 20
- Join now to see all
Publications & Presentations
PubMed
- Patients with advanced ovarian cancer and their experiences and perceptions of sleep disturbance and fatigue across the treatment trajectory: A qualitative study.Abigail Newell, Elif Andac-Jones, Maria Gonzalo, Alexi A Wright, Oxana Palesh
Gynecologic Oncology. 2025-05-23 - Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Madeline Polak, Susana Campos
Gynecologic Oncology. 2025-05-19 - 1 citations"You Want to Shield Your Kids": Patients' and Their Adult-Children's Serious Illness Conversations.Anny Thr Fenton, Bernadette Blashill, Anna C Revette, Alexis Mann, Maija Reblin
Journal of Pain and Symptom Management. 2025-05-01
Press Mentions
F.D.A. Approves First at-Home Alternative to the Pap SmearMay 9th, 2025- Dana-Farber Experts Present Innovative Cancer Studies at the 2025 AACR Annual MeetingApril 26th, 2025
- Dana-Farber Research Highlights Head and Neck, Breast, Lung, and Survivorship Studies at AACR Annual Meeting 2025April 25th, 2025
- Join now to see all
Grant Support
- A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
- A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
- A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
- A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
- A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
- Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitorsDANA-FARBER CANCER INST2024–2029
- BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028
- BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
